In Vitro Models for Predicting Transporter-Mediated DDIs
This paper discusses how in vitro studies can be used to predict drug-drug interactions (DDIs) caused by transporters in the body.
This paper discusses how in vitro studies can be used to predict drug-drug interactions (DDIs) caused by transporters in the body.
ADC immunogenicity demands more than a standard ADA assay. Resolian’s tiered, domain-specific approach delivers regulatory-ready results across the full method lifecycle.
CASE STUDY – ANTI-AAV ANTIBODIES. We are experienced with a wide range of different proteins and therapeutics…
Whereas blood is collected for analysis at a discrete time point, urine is collected over periods of time known as collection intervals…
Bispecifics (Bs) are biopharmaceutical products that bind to two different targets (epitopes). These are mainly two types: IgG-like (antibodies Abs) and non-IgG-like which include Bites (bispecific T-cell engager) and DARTs (Dual-affinity Re-targeting Antibody)…
Liquid chromatography linked to tandem mass spectrometry (LC–MS/MS, LC-MS) is the “go-to” method for pharmacokinetics and metabolism studies across drug development with recent advances in separation, throughput and methods for analyzing protein biotherapeutics…
In this Bioanalysis Zone podcast episode, our Senior Scientist and Technical Specialist Ashley Phillips discusses his recent publication…
LC-MS/MS assay development within Bioanalysis is driven by developing accurate, precise and robust methods within the shortest time frame possible…
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a powerful technique in the field of bioanalysis, and it plays a critical role in drug development and clinical trials…
How Resolian’s experienced team identifies and quantifies trace impurities in a diverse range of materials through nitrosamines analysis.